CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $298,000 | +3.5% | 16,228 | +3.2% | 0.00% | – |
Q3 2020 | $288,000 | +7.5% | 15,730 | -12.2% | 0.00% | – |
Q2 2020 | $268,000 | -4.6% | 17,909 | +1.0% | 0.00% | -100.0% |
Q1 2020 | $281,000 | +2.2% | 17,735 | +4.6% | 0.00% | – |
Q4 2019 | $275,000 | +12.2% | 16,949 | +3.0% | 0.00% | – |
Q3 2019 | $245,000 | -13.1% | 16,459 | -3.5% | 0.00% | -100.0% |
Q2 2019 | $282,000 | +8.9% | 17,054 | +13.7% | 0.00% | 0.0% |
Q1 2019 | $259,000 | -4.8% | 14,998 | -2.5% | 0.00% | 0.0% |
Q4 2018 | $272,000 | +45.5% | 15,377 | +49.2% | 0.00% | – |
Q3 2018 | $187,000 | -10.1% | 10,303 | -3.3% | 0.00% | – |
Q2 2018 | $208,000 | +39.6% | 10,650 | -15.5% | 0.00% | – |
Q1 2017 | $149,000 | -5.7% | 12,601 | +4.7% | 0.00% | – |
Q4 2016 | $158,000 | -25.5% | 12,033 | -17.7% | 0.00% | -100.0% |
Q3 2016 | $212,000 | +22.5% | 14,614 | +1.5% | 0.00% | 0.0% |
Q2 2016 | $173,000 | -13.5% | 14,394 | +54.7% | 0.00% | 0.0% |
Q4 2015 | $200,000 | -31.3% | 9,307 | +20.2% | 0.00% | 0.0% |
Q2 2015 | $291,000 | – | 7,745 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
S. MUOIO & CO. LLC | 52,468 | $964,000 | 1.05% |
Olympiad Research LP | 54,795 | $1,007,000 | 0.58% |
Alpine Global Management, LLC | 119,902 | $2,204,000 | 0.45% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 65,922 | $1,212,000 | 0.19% |
First Trust Capital Management L.P. | 32,688 | $601,000 | 0.17% |
GLAZER CAPITAL, LLC | 232,103 | $4,266,000 | 0.15% |
Walleye Capital LLC | 105,000 | $1,930,000 | 0.13% |
Yakira Capital Management, Inc. | 17,588 | $323,000 | 0.08% |
Dynamic Technology Lab Private Ltd | 17,929 | $330,000 | 0.05% |
EQUITEC PROPRIETARY MARKETS, LLC | 10,600 | $195,000 | 0.05% |